The size of the global pigmented lesion treatment market is anticipated to grow at a healthy growth rate from 2023 to 2028.
Pigmented Lesion Treatment is one of the most common skin diseases affecting the elderly population. The most frequently affected region is the face; nevertheless, marks can still emerge on other body parts. It is primarily a consequence of aging and extreme sun exposure. Other causes may include endogenous and exogenous, both malignant and aetiologies. Nowadays, various therapies, laser treatments, and medications can effectively treat and remove these marks. Introduction of non-invasive med-aesthetic systems by Pharmaceutical companies that can efficiently lessen the impact of the condition. These novel medications are reliable, safe, and comfortable.
MARKET DRIVERS:
The growing aging population and rising regularity in pigmentation disorders primarily heighten the global pigmented lesion treatment market growth.
The growing demand for the cure and removal of pigmented lesions among the elderly population is forcing big companies to develop advanced treatment modules that deliver superior results and are cost-effective, thereby driving the market growth. Research and development in the pigment lesion treatment field have allowed big companies to manufacture non-invasive med-aesthetic systems to treat severe impacts of Pigmented lesions Treatments efficiently. Due to their comfort and effectiveness, these treatments rapidly gain popularity and trust among patients.
The presence of well-established healthcare infrastructure for treating patients and existing market key players provide efficient treatment in patients with post-inflammatory hyperpigmentation. Moreover, factors such as growing aesthetic awareness and the regular ubiquity of pigmented lesions bolster the market demand over the review period. Chronic alcohol consumption habits, increasing adoption of synthetic cosmetic products, and new medications and treatments foster the need for pigmented lesions.
MARKET RESTRAINTS:
Simultaneously, the development of pigment devices has led to enhanced patient safety and has removed adverse side effects, which are estimated to hinder market growth. Adverse effects of laser treatments such as skin swelling, itching, and redness, along with chances of hyperpigmentation, scarring, blistering, and infections, are likely to be central in rare cases that may hinder the market growth. Lack of awareness regarding laser treatment and shortage of skilled professionals impede the pigmented lesion treatment market growth.
Impact of COVID-19 on the global pigmented lesion treatment market:
The COVID-19 pandemic has shown a quantifiable impact on the economy, in turn on pigmented lesion treatment market. The drugs taken by the COVID-19 patients may have adverse effects on their skin, resulting in pigmentation. Governments have imposed guidelines to prevent the stoppage of the disease. The launch of new skincare products, drugs, and approvals have paused their activities as they face trading restrictions. During the lockdown period, patients haven't visited dermatologists to get their skin problems healed. Due to this, there was a slight decline in the healthcare economy around the world. Tele-consultations were more adopted meeting the patients virtually. After the lockdown had uplifted, the patients started visiting their skin specialists, following all the precautions for their safety.
REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2022 to 2028 |
Base Year |
2022 |
Forecast Period |
2023 to 2028 |
Segments Covered |
By Product, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
This market research report on the global pigmented lesion treatment market has been segmented and sub-segmented based on the product, end-user, and region.
Pigmented Lesion Treatment Market - By Product:
The IPL devices segment accounted for the largest share of the market based on the product, followed by energy-based devices.
The energy-based devices segment is expected to perform well in the global pigmented lesion treatment market. The segment growth is due to technological advancements in therapeutic techniques like the invention of new laser and energy-based treatments together with high-level equipment handling devices. The growing demand for treatment techniques with quick recovery, less pain, and post-treatment infections further increases market growth.
Pigmented Lesion Treatment Market - By End User
Based on end-user, the Dermatology segment is expected to dominate the end-user segment in revenue. Well-established healthcare infrastructure, skilled professionals, and specialists are driving the growth of this segment.
Pigmented Lesion Treatment Market - By Region
North America accounted for the largest share of the Pigmented Lesion Treatment market, followed by Europe and the Asia Pacific. It can be accredited to the growing awareness among consumers regarding accessibility to various Pigmented Lesion Treatment devices. Factors such as the widespread presence of leading market players in the region and the availability of advanced skin treatment techniques are key factors governing the market growth in this region. Besides, a large portion of the geriatric population in this region is increasingly opting for skincare therapies to enhance their look and reduce the risk of skin-related diseases.
KEY MARKET PARTICIPANTS:
Some of the most promising companies operating in the global pigmented lesion treatment market profiled in this report are Alma Lasers Ltd., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences Inc., Fotona d.d., Sciton, Inc., EL.En. S.p.A., Lynton Lasers Ltd, Solta Medical Inc., Syneron Medical Ltd., Lutronic Corporation, and Cutera Inc.
KEY HAPPENINGS IN THIS MARKET IN THE RECENT PAST:
FAQ's
Some of the major companies operating in the pigmented lesion treatment market include Alma Lasers, Cutera, Cynosure, Lumenis, Sciton, Syneron Candela, and Valeant Pharmaceuticals.
Some of the key trends in the pigmented lesion treatment market include the increasing demand for non-invasive and minimally invasive procedures, the development of advanced laser technologies, and the growing trend towards personalized medicine.
Some of the key challenges facing the pigmented lesion treatment market include the high cost of treatment, the need for specialized training and expertise, and the risk of adverse events and complications.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]